Catalyst Wire Dossier Catalyst Wire Dossier

Bryostatin-1

bryostatin-1 · Neurotrope Bioscience, Inc.
Drug timelines are a Plus or Pro feature.

39 regulatory and trial events tracked for Bryostatin-1, covering 2008-02-01 to 2024-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Bryostatin Treatment of Moderately Severe Alzheimer's Disease [Phase 2]

See pricing